Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Interview: Bruno Strigini, MSD

MSD’s president, Europe and Canada, on how pharma is adapting to the market’s new reality

- PMLiVE

Icon appoints Hugh Brady to board

He is former president of University College Dublin

- PMLiVE

Otsuka wins approval for TB drug Deltyba

Second drug approved by EC in 2014 for multidrug resistant tuberculosis

- PMLiVE

Breo off to slow start in US as Advair slips, says GSK

And China issues continue to affect sales performance

- PMLiVE

Reckitt Benckiser backtracks on Merck OTC unit

Ends negotiations to add to consumer health division

Michael Fleming joins biosimilars firm Coherus

He has experience at Elan, Genentech and GSK

- PMLiVE

Augé Reichenberg joins McCann HumanCare

She becomes executive creative director of consumer health-focussed agency

- PMLiVE

Novartis teams up with artist in meningitis campaign

Digital book contains photos of disease survivors taken by Anne Geddes

Novartis building

Novartis gets US nod for lung cancer relapse therapy Zykadia

Second ALK inhibitor to be approved after Pfizer’s Xalkori

Bristol-Myers Squibb (BMS) building

BMS buys Alzheimer’s player iPierian in $725m deal

Takes control of several promising candidates for neurodegenerative diseases

Biomarin

EC approves Biomarin rare genetic disorder drug

Vimizim now available to treat Morquio A syndrome

- PMLiVE

CTI launches cancer drug Pixuvri in UK

Now available to treat form of non-Hodgkin lymphoma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links